Author:
Fenton Caroline,Kang Connie
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Gravas S, Cornu JN, Gacci M, et al. Management of non-neurogenic male LUTS. 2021. https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/. Accessed 25 Jan 2023.
2. Kao Y-L, Ou Y-C, Kuo H-C. Bladder dysfunction in older adults: the botulinum toxin option. Drugs Aging. 2022;39(6):401–16.
3. Shaw C, Wagg A. Overactive bladder in frail older adults. Drugs Aging. 2020;37(8):559–65.
4. Ginsberg DA, Boone TB, Cameron AP, et al. The AUA/SUFU guideline on adult neurogenic lower urinary tract dysfunction: diagnosis and evaluation. J Urol. 2021;206(5):1097–105.
5. Kaplan SA, Roehrborn CG, Rovner ES, et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006;296(19):2319–28.